Literature DB >> 26761532

Imaging of Drug-induced Complications in the Gastrointestinal System.

Melissa J McGettigan1, Christine O Menias1, Zhenqiang J Gao1, Vincent M Mellnick1, Amy K Hara1.   

Abstract

Drug-induced injury commonly affects the gastrointestinal and hepatobiliary systems because of the mechanisms of absorption and metabolism. In pill esophagitis, injury is frequently related to direct contact with the esophageal mucosa, resulting in small superficial ulcers in the mid esophagus. Nonsteroidal anti-inflammatory drugs can lead to gastrointestinal tract ulcers and small bowel mucosal diaphragms (thin weblike strictures). Injury to the pancreatic and hepatobiliary systems can manifest as pancreatitis, acute or chronic hepatitis, cholestasis, or steatosis and steatohepatitis (which may progress to cirrhosis). Various drugs may also insult the hepatic vasculature, resulting in Budd-Chiari and sinusoidal obstructive syndromes. Focal lesions such as hepatic adenomas may develop after use of oral contraceptives or anabolic steroids. Ultrasonography, computed tomography, and magnetic resonance imaging can aid in diagnosis of drug-induced injuries and often are necessary to exclude other causes. ©RSNA, 2015.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26761532     DOI: 10.1148/rg.2016150132

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  2 in total

Review 1.  Pneumatosis Intestinalis Induced by Alpha-Glucosidase Inhibitors in Patients with Diabetes Mellitus.

Authors:  Blake J McKinley; Mariangela Santiago; Christi Pak; Nataly Nguyen; Qing Zhong
Journal:  J Clin Med       Date:  2022-10-07       Impact factor: 4.964

2.  Hydrogen Sulfide Releasing 2-Mercaptoacrylic Acid-Based Derivative Possesses Cytoprotective Activity in a Small Intestine of Rats with Medication-Induced Enteropathy.

Authors:  Yulia Sklyarova; Iryna Fomenko; Iryna Lozynska; Andrii Lozynskyi; Roman Lesyk; Alexandr Sklyarov
Journal:  Sci Pharm       Date:  2017-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.